etanidazole has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilder, RB | 1 |
| McGann, JK | 1 |
| Sutherland, WR | 1 |
| Waller, EK | 1 |
| Minchinton, AI | 1 |
| Goris, ML | 1 |
| Knox, SJ | 1 |
1 other study available for etanidazole and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Etanidazole; Humans; Lymphoma, Non-Hodgki | 1994 |